Compass Pathways Plc

Stock Chart, Company Information, and Scan Results

$5.39(as of Nov 18, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Compass Pathways Plc Company Information, Fundamentals, and Technical Indicators

Stock Price$5.39
Ticker SymbolCMPS
ExchangeNasdaq
SectorHealthcare
IndustryMedical Care Facilities
Employees166
CountyUSA
Market Cap$511.8M
EBIDTA-154.4M
10-Day Moving Average5.50
P/E Ratio-2.17
20-Day Moving Average5.93
Forward P/E Ratio0.00
50-Day Moving Average5.88
Earnings per Share-2.72
200-Day Moving Average4.42
Profit Margin-Infinity%
RSI42.58
Shares Outstanding96.0M
ATR0.45
52-Week High7.09
Volume1,233,165
52-Week Low2.25
Most Recent Support Level5.01
Book Value37.6M
Most Recent Resistance Level6.01
P/B Ratio13.67
Upper Keltner6.95
P/S RatioInfinity
Lower Keltner4.91
Debt-to-Equity Ratio6.95
Next Earnings DateUnknown
Cash Surplus-11.5M
Next Ex-Dividend DateUnknown

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Compass Pathways Plc In Our Stock Scanner

As of Nov 19, 2025
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.